| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |